Elevance Health (ELV) has shared an update.
Elevance Health, Inc. is set to reassure investors about its robust financial outlook, projecting a net income for full year 2024 exceeding $34.29 per share, despite some unfavorable factors. Adjusted predictions, not including these factors, anticipate even higher earnings. Additionally, four of their Medicare Advantage contracts have received upgraded Star Ratings from CMS, which is expected to benefit 2025 revenues by approximately $190 million. This financial uplift is attributed to about half of the Medicare Advantage members now being in plans with a 4-Star rating or higher.
See more insights into ELV stock on TipRanks’ Stock Analysis page.
